The Discovery & Development US 2025 supports biopharma leaders in accelerating the journey from target identification to clinical candidate, with a focus on optimizing drug discovery and development workflows.
Topics
AI and machine learning-guided engineering and discovery
Preclinical studies and safety for small and large molecule drugs
Advanced drug delivery methods, including RNA, peptide, and oligonucleotide delivery
Exploring sustainable and innovative drug development practices
Biologics innovation, including ADCs, antibody design, and next-gen targets
Targeting neurodegenerative diseases with organoids and iPSC models
Translating drug targets into clinical therapies
Pharmacology, DMPK, and optimizing formulation and delivery
Small and large molecule formulation and delivery breakthroughs
Medicinal and computational chemistry for target validation
